ENTITY

Arecor Therapeutics (AREC LN)

1
Analysis
Health Care • United Kingdom
Arecor Therapeutics PLC is a clinical-stage biopharmaceutical company focused on developing superior therapeutics to address unmet patient needs in diabetes, obesity, and other cardiometabolic diseases. The company utilizes its proprietary Arestat® formulation technology platform to create enhanced reformulations of therapeutic products and to develop a portfolio of proprietary products, including AT278, an ultra-rapid acting insulin. Arecor Therapeutics plc was founded in 2007 and is headquartered in Little Chesterford, United Kingdom.
more
Company Event • 22 Apr 2027 18:00 • Upcoming
Add To Calendar

H2 2026

Company Event • 30 Sep 2026 14:00 • Upcoming
Add To Calendar

H1 2026

Company Event • 08 Sep 2022 06:00 • Upcoming
Add To Calendar

H1 2022

No more events
x